-
Subject Areas on Research
-
A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
-
A multicenter study of anticoagulation parameters when using heparin and warfarin.
-
A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA).
-
Acquired hypoprothrombinemia: effects of danazol treatment.
-
Acute pancreatitis and fulminant hepatic failure.
-
Adaptive force sonorheometry for assessment of whole blood coagulation.
-
An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS).
-
Anticardiolipin antibodies and osteonecrosis of the femoral head.
-
Association of Ozone Exposure With Cardiorespiratory Pathophysiologic Mechanisms in Healthy Adults.
-
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.
-
Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.
-
Coagulation abnormalities and thrombosis in patients with COVID-19.
-
Coagulation abnormalities in patients with hip osteonecrosis.
-
Coagulation changes in elective surgery and trauma.
-
Coagulation in Liver Disease.
-
Coagulopathy in COVID-19.
-
Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients.
-
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers.
-
Controlled Multifactorial Coagulopathy: Effects of Dilution, Hypothermia, and Acidosis on Thrombin Generation In Vitro.
-
Cross circulation between children in hepatic coma and chimpanzees. Clinical, biochemical, and coagulation observations.
-
Decreased sensitivity to warfarin in patients with myxedema.
-
Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation.
-
Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures.
-
Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation.
-
Do anticoagulation management services improve care? Implications of the Managing Anticoagulation Services Trial.
-
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study.
-
Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
-
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.
-
Erythromycin-induced digoxin toxicity.
-
Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
-
Evaluation of p-amidinophenyl esters as potential antithrombotic agents.
-
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.
-
Fully printed prothrombin time sensor for point-of-care testing.
-
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
-
How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
-
Hypercalcemia. A complication of advanced chronic liver disease.
-
Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial.
-
In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
-
International normalized ratio.
-
Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure.
-
Magnetic resonance imaging and hepatic hemodynamics: correlation with metabolic function in liver transplantation candidates.
-
Malfunction of the liver after transplantation: an analysis of potential risk factors.
-
Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.
-
Monitoring warfarin therapy in patients with lupus anticoagulants.
-
Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
-
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.
-
Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation.
-
Pretransplant status and patient survival following liver transplantation.
-
Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.
-
Procoagulant and platelet aggregating properties of antilymphocyte sera.
-
Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature.
-
Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation.
-
Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans.
-
Prothrombin and beta 2-glycoprotein I frequently contribute to antiphospholipid antibody interactions with phospholipids and the generation of abnormal waveform profiles in coagulation assays.
-
RE: The prothrombin time ratio is not a more effective marker for evaluating sepsis-induced coagulopathy than fibrin-related markers: Response to the Letter-to-the-Editor by Dr Wada.
-
RNA aptamers as reversible antagonists of coagulation factor IXa.
-
Response to warfarin in hypothyroid rats.
-
Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.
-
Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers.
-
Spontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis.
-
Ten-year results with the St. Jude Medical prosthesis.
-
The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations.
-
The coagulation cascade in cirrhosis.
-
The effect of temperature variation in vitro on platelet-leukocyte interactions and individual prothrombotic potential.
-
The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial.
-
The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS).
-
The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery.
-
The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
-
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
-
Keywords of People